Shortly after a similarly sized venture from Pfizer, French pharma juggernaut Sanofi has unveiled a major manufacturing ...

Sanofi plans to phase in its own rebate model for 25 drugs — including anti-inflammatory injectable Dupixent, one of the top ...

In a bid to bolster pandemic preparedness, Sanofi has opened a modular vaccine manufacturing plant in Tuas Biomedical Park, ...

Sanofi plans to invest around 1 billion euros ($1.05 billion) to build a new insulin production base in Beijing, which will ...

Regeneron Pharmaceuticals Inc. claims that a partner has broken a collaboration deal by refusing to reveal side deals for marketing ...

Two months after Sanofi completed construction in France of its innovative Modulus vaccine and biologics plant—which can be ...

Hudson says many CEOs are scared of AI, comparing it to The Terminator’s John Connor traveling back in time to stop the rise ...

Sanofi has officially opened a modular biologics manufacturing facility in Singapore that is designed to allow rapid ...

Zeid Barakat started the discussion by highlighting how, when executed well, CMC represents a key strategic asset. When ...

Sanofi’s (NASDAQ:SNY) growth is propelled by strong demand for its flagship drugs such as Dupixent (for asthma and eczema) ...

A roundup of significant health updates globally includes Sanofi's major investment in China, New Zealand suspending poultry ...